Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
Clicks: 228
ID: 265909
1997
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
5.4
/100
18 views
18 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The availability of reproducible antifungal susceptibility testing methods now permits analysis of data correlating susceptibility in vitro with outcome in vivo in order to define interpretive breakpoints. In this paper, we have examined the conceptual framework underlying interpretation of antimicr …
| Reference Key |
jh1997clinicaldevelopment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rex JH;Pfaller MA;Galgiani JN;Bartlett MS;Espinel-Ingroff A;Ghannoum MA;Lancaster M;Odds FC;Rinaldi MG;Walsh TJ;Barry AL;; |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Year | 1997 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mice
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
drug resistance
microbial
m a pfaller
antifungal agents / pharmacology*
candidiasis / drug therapy*
j h rex
pmid:9114154
doi:10.1093/clinids/24.2.235
a l barry
fluconazole / pharmacology*
itraconazole / pharmacology*
microbial sensitivity tests*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.